company background image
VTRS logo

Viatris NasdaqGS:VTRS Stock Report

Last Price

US$11.94

Market Cap

US$14.0b

7D

-0.6%

1Y

24.9%

Updated

28 Mar, 2024

Data

Company Financials +

Viatris Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Viatris
Historical stock prices
Current Share PriceUS$11.94
52 Week HighUS$13.62
52 Week LowUS$8.74
Beta1.14
1 Month Change-9.75%
3 Month Change10.25%
1 Year Change24.90%
3 Year Change-14.10%
5 Year Change-56.46%
Change since IPO1,847.26%

Recent News & Updates

Up 25%, I Still Believe 4%-Yielding Viatris Is Up To 60% Undervalued

Mar 02

Recent updates

Up 25%, I Still Believe 4%-Yielding Viatris Is Up To 60% Undervalued

Mar 02

From Euphoria To Reality: Viatris' Tale Of Market Whirlwind

Jan 12

Viatris stock rises amid potential plans for €3B sale of European OTC assets

Oct 11

Take These Broken Wings And Learn To Fly Again Viatris

Sep 25

Viatris: 5% Dividend Yield Is A Threat For Investors

Sep 06

Viatris: Products, Profitability And Pipeline - The Keys To Success

Aug 20

Viatris declares $0.12 dividend

Aug 08

Viatris: A Spinoff To Own

Aug 02

Viatris extends decline to reach 52-week low

Jul 22

Viatris: Guidance Likely To Be Cut With Q2 Results

Jul 15

Viatris: The Market Is Not Buying It - Downtrend Since 2015

May 09

Viatris: 3 Things That Can Break The Bull Thesis In 2022

Apr 20

I No Longer Think Viatris Is A Buy

Apr 08

Viatris: Takeaways From Management At The Raymond James Conference

Mar 10

My Investment Thesis On Viatris Remains Intact After The Sale Of The Biosimilars Assets

Feb 28

Shareholder Returns

VTRSUS PharmaceuticalsUS Market
7D-0.6%2.2%0.2%
1Y24.9%25.5%28.1%

Return vs Industry: VTRS matched the US Pharmaceuticals industry which returned 25.5% over the past year.

Return vs Market: VTRS underperformed the US Market which returned 28.1% over the past year.

Price Volatility

Is VTRS's price volatile compared to industry and market?
VTRS volatility
VTRS Average Weekly Movement4.6%
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: VTRS has not had significant price volatility in the past 3 months.

Volatility Over Time: VTRS's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
196138,000Scott Smithhttps://www.viatris.com

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).

Viatris Inc. Fundamentals Summary

How do Viatris's earnings and revenue compare to its market cap?
VTRS fundamental statistics
Market capUS$14.05b
Earnings (TTM)US$54.70m
Revenue (TTM)US$15.43b

259.2x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VTRS income statement (TTM)
RevenueUS$15.43b
Cost of RevenueUS$8.69b
Gross ProfitUS$6.73b
Other ExpensesUS$6.68b
EarningsUS$54.70m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.046
Gross Margin43.64%
Net Profit Margin0.35%
Debt/Equity Ratio88.5%

How did VTRS perform over the long term?

See historical performance and comparison

Dividends

4.0%

Current Dividend Yield

1,053%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.